Vast Therapeutics
PrivateLast Round
Grant
Sep 16, 2025
Est. Valuation
$49.85M
Total Funding Raised
$35.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vast Therapeutics operates in Healthcare & Life Sciences and is based in Morrisville, North Carolina. Its latest recorded funding round was a Grant round in September 2025.
Vast Therapeutics is a clinical-stage life sciences company that develops nitric oxide-based medicines for patients with chronic respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vast Therapeutics Comparables
Compare Vast Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novoteris, LLC | 88% | |
| Revagenix, Inc. | 76% | |
| Matinas BioPharma Holdings, Inc. | 70% |
For institutional investors. Book with your work email.
Vast Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 16, 2025 | ||||
| Series B | Mar 17, 2025 | ||||
| Grant | Jan 21, 2025 | ||||
| Grant | Jan 16, 2019 | ||||
| Series A | Jan 16, 2019 | ||||
Grant | Dec 13, 2018 |
For institutional investors. Book with your work email.
Vast Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shionogi & Co. | Series A |
| NIH RADx | Grant |
| Cystic Fibrosis Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 82% MoM.
- Sep 16, 2025
Secured $2M from NIH RADx.
For institutional investors. Book with your work email.
Vast Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vast Therapeutics's valuation, stock price, and market status.
Is Vast Therapeutics a public or private company?
Vast Therapeutics is a private company.
What is the current stock price of Vast Therapeutics?
Vast Therapeutics is a private company, so its shares have no public market price. Caplight tracks Vast Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vast Therapeutics worth (valuation)?
Vast Therapeutics's valuation is estimated at $49.9M based on funding round data.
Can I buy Vast Therapeutics stock?
Vast Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vast Therapeutics's last funding round?
Vast Therapeutics's most recent funding round was Grant on September 16, 2025.
Who are the main investors in Vast Therapeutics?
Key investors in Vast Therapeutics include Shionogi & Co..
Will Vast Therapeutics IPO soon?
No public IPO plans have been announced for Vast Therapeutics.
How can I track Vast Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Vast Therapeutics's shares on secondary markets.